LiquidHALLMARK®
Multi-Cancer Screening
Resources
- Publications
- News & Events
Patients
Company
Portal Login

Lucence secures US Medicare approval for its cancer tests

News | March 20, 2023

Share on |

Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

Reach Us

3520 W Bayshore Road, Palo Alto, CA 94303 [email protected] (888) 582 3623

Subscribe for Updates

Follow Us

© 2023 Lucence Health Inc. All rights reserved. All logos and trademarks are the property of Lucence or their respective owners.

LiquidHALLMARK® | AmpliMark™ | Publications| Careers | About | Privacy

Order Terms

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO

>